Science & Enterprise subscription

Follow us on Twitter

  • Our #podcast is now live ... NPC Members Display Photos At Annual Club Exhibit https://t.co/EsClVw9ZNc @pressclubdc #NPCPhotoEx
    about 1 day ago
  • More Democrats say they're in favor of increased federal spending on scientific research than Republicans, a gap th… https://t.co/SQBna2FykD
    about 1 day ago
  • New post on Science and Enterprise: Infographic – Partisan Split Remains on Research Spending https://t.co/FabPa5ufSb #Science #Business
    about 1 day ago
  • The first participant in a clinical trial received an experimental minimally-invasive brain implant to record brain… https://t.co/nPUNY6S2a5
    about 2 days ago
  • New post on Science and Enterprise: Trial Underway Testing Brain-Computer Implant https://t.co/olPDnbtfnW #Science #Business
    about 2 days ago

Please share Science & Enterprise

Trial Underway Testing Brain-Computer Implant

Stentrode implant

The first participant in a clinical trial received an experimental minimally-invasive brain implant to record brain signals, testing the implant’s feasibility for assistive technology. . . . → Read More: Trial Underway Testing Brain-Computer Implant

Opioid Abuse Treatment Medications Underused

Head in hands

While three medications for opioid abuse are approved by the Food and Drug Administration, the treatments are used sparingly in therapy according to a new review of data. . . . → Read More: Opioid Abuse Treatment Medications Underused

First Therapies Selected for Multi-Drug ALS Trial

Brain cell networks

A clinical trial is getting underway to test five treatment candidates for amyotrophic lateral sclerosis, or ALS, beginning with the first three therapies. . . . → Read More: First Therapies Selected for Multi-Drug ALS Trial

Start-Up Targets Extra DNA in Cancer, Raises $46.4M

Paul Mischel

A new biotechnology enterprise is developing treatments for aggressive solid tumor cancers that block the effects of DNA residing outside of chromosomes. . . . → Read More: Start-Up Targets Extra DNA in Cancer, Raises $46.4M

Trial Shows Radio Waves Safe for Alzheimer’s Therapy

brain stimulationgraphic

Results from a small clinical trial show a treatment for Alzheimer’s disease using radio waves is safe and offers early evidence it can reverse memory loss. . . . → Read More: Trial Shows Radio Waves Safe for Alzheimer’s Therapy

Clinical Research Sites Open in Canadian Walmart Stores

Walmart entrance

A collaboration between a research company and local health clinic chain is enabling customers at Walmart stores across Canada to take part in clinical research studies. . . . → Read More: Clinical Research Sites Open in Canadian Walmart Stores

Gel, Crispr Help Defeat Cancer Drug Obstacles

Crispr-Cas9 illustration

A high-powered binding protein, formulated as a gel and targeted by Crispr gene editing is shown in lab mice to precisely deliver drugs and kill cancer cells. . . . → Read More: Gel, Crispr Help Defeat Cancer Drug Obstacles

Migraine Drug Developer Raises $82.5M in IPO

NASDAQ share price display

A developer of a drug for migraine formulated as a dry powder and given as a nasal spray is raising $82.5 million in its initial public offering of common stock. . . . → Read More: Migraine Drug Developer Raises $82.5M in IPO

NIH Funds Augmented-Reality Endovascular System

Heart, circulation system

A grant from National Institutes of Health is funding a system using augmented reality and holography to improve minimally-invasive repair of blood vessels. . . . → Read More: NIH Funds Augmented-Reality Endovascular System

Hydrogel Shown Safe to Repair Heart Damage

Karen Christman

Results of a small-scale clinical trial show an experimental treatment using an injectable gel to repair damage from a heart attack is safe for patients. . . . → Read More: Hydrogel Shown Safe to Repair Heart Damage